IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teladoc Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Companies Mentioned:

Primary Exchange: NYSE
Under the Symbol: TDOC

$51.60

$1.74

3.49%


IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teladoc Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Friday, January 11, 2019 5:40 PM

LOS ANGELES, CA / ACCESSWIRE / January 11, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teladoc Health, Inc. ("Teladoc Health" or "the Company") (NYSE: TDOC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's shares between March 3, 2016 and December 5, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before February 11, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Teladoc Health's CFO and COO, Mark Hirschhorn, carried on an affair with a subordinate. Hirschhorn and his partner in the inappropriate sexual relationship engaged in insider trading to enrich themselves based on stock movement. Hirschhorn also caused the subordinate to receive promotions she was not qualified to receive, harming the Company's performance. The Company's internal controls and policies were not sufficient to detect and stop the behavior. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Teladoc Health, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
Sherin Mahdavian, Esq.,
www.schallfirm.com
424-303-1964
[email protected]

SOURCE: The Schall Law Firm


Subscribe to alerts from Investor Network
SHARE ARTICLE